Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Other financing activities (2019 - 2022)

Purple Biotech has reported Other financing activities over the past 4 years, most recently at $17.8 million for Q1 2022.

  • Quarterly Other financing activities rose 1269.23% to $17.8 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $29.6 million through Mar 2022, changed N/A year-over-year, with the annual reading at $8.0 million for FY2022, 39.23% down from the prior year.
  • Other financing activities was $17.8 million for Q1 2022 at Purple Biotech, up from $5.0 million in the prior quarter.
  • Over five years, Other financing activities peaked at $17.8 million in Q1 2022 and troughed at -$49.6 million in Q4 2020.
  • The 4-year median for Other financing activities is $5.0 million (2019), against an average of -$2.5 million.
  • Year-over-year, Other financing activities tumbled 1090.18% in 2020 and then skyrocketed 1269.23% in 2022.
  • A 4-year view of Other financing activities shows it stood at $5.0 million in 2019, then tumbled by 1090.18% to -$49.6 million in 2020, then soared by 110.07% to $5.0 million in 2021, then surged by 256.21% to $17.8 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Other financing activities are $17.8 million (Q1 2022), $5.0 million (Q4 2021), and $5.5 million (Q2 2021).